Question 1

Who owns IPHA?

Accepted Answer

INNATE PHARMA S A (IPHA) is held by 6 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is MORGAN STANLEY as of Q1 2026.

Question 2

Are institutions buying or selling IPHA?

Accepted Answer

In Q1 2026, 0 institutions opened or increased positions in INNATE PHARMA S A while 6 reduced or exited — a net selling quarter.

Question 3

What is the Smart Money Verdict on IPHA?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for INNATE PHARMA S A.

Question 4

How many hedge funds hold IPHA?

Accepted Answer

6 institutional investors report holding INNATE PHARMA S A (IPHA) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into IPHA?

Accepted Answer

As of Q1 2026, tracked institutions in INNATE PHARMA S A show 0 buyers versus 6 sellers — net outflows.

Fund	Action	Shares	Value	Weight	Est. P&L
MORGAN STANLEY	Decreased	43,524(-6.2%)	$55,711	0.0%	-6.86%
JANE STREET GROUP, LLC	Decreased	43,365(-53.3%)	$55,507	0.0%	+2.87%
MILLENNIUM MANAGEMENT LLC	Decreased	10,064(-50.4%)	$12,882	0.0%	+2.87%
RHUMBLINE ADVISERS	Decreased	4,734(-9.0%)	$6,057	0.0%	-0.07%
UBS Group AG	Decreased	861(-9.1%)	$1,102	0.0%	-13.59%
Farther Finance Advisors, LLC	Unchanged	10	$14	0.0%	-1.65%
BARCLAYS PLC	Exited	0(-100.0%)	$2	0.0%	-56.74%

INNATE PHARMA S A

Continue exploring

Other Healthcare stocks held by institutions